A document prepared for the FDA Advisory Committee meeting, in which members voted seventeen to zero in favour of giving emergency use authorisation for the administration of the Pfizer Covid-19 injection to children aged 5 to 11, confirms that Pfizer have modified the formulation of their injection for children to include an ingredient that reduces the acidity of blood and is used to stabilise people who have suffered a heart attack.

“Authorization is being requested for a modified formulation of the Pfizer‑BioNTech COVID-19 Vaccine. Each dose of this formulation contains 10 μg of a nucleoside-modified messenger RNA (mRNA) encoding the viral spike (S) glycoprotein of SARS-CoV-2 that is formulated in lipid particles and supplied as a frozen suspension in multiple dose vials.”

“To provide a vaccine with an improved stability profile, the Pfizer-BioNTech COVID-19 Vaccine for use in children 5-11 years of age uses tromethamine (Tris) buffer instead of the phosphatebuffered saline (PBS) as used in the previous formulation and excludes sodium chloride and potassium chloride”. 

THE 90% EFFECTIVE CLAIM IS MEANINGLESS

The Pfizer risk and benefit analysis presented to the FDA for EUA approval, states that resulting from their clinical trials they have found the COVID-19 vaccine to be 90.7% effective at preventing symptomatic disease in children ages five to 11. The UKs Joint Committee on Vaccination and Immunisation (JCVI) have said that the evidence strongly indicates that almost all children and young people are at very low risk from COVID-19.

Where symptoms are seen in children and young people, they are “typically mild, and little different from other mild respiratory viral infections which circulate each year”.  Children also recover from these infections quickly and according to many studies develop a robust broad spectrum immunity.

The rates in 5 to 11 are so low that there were no “cases” of severe COVID-19 or death from either the treatment (n= 1,518) or control group (n= 750), this renders the “90% effective” claim, meaningless. This should have stopped an EUA application in its tracks, as clearly there is no emergency for this age group in particular and therefore no benefit either.

Read More – https://dailyexpose.uk/2021/11/01/pfizer-adds-ingredient-to-vaccine-for-kids-that-treats-heart-attacks/